Disposition, intestinal absorption and drug metabolizing enzyme activities after multiple doses of indomethacin in rat and effect of antacid and dicyclomine on the parameters.
The effect of repeated treatment with indomethacin (IND) on the disposition and intestinal absorption of the drug and microsomal drug-metabolizing enzyme activities were studied in comparison with coadministration of the drug and magnesium silicate or dicyclomine in male Wistar rats. The plasma decay curve of IND following a rapid i.v. injection (6 mg/kg) was found to be biexponential. The elimination rate constant (beta) of beta phase was 0.138 +/- 0.015 h-1. The beta after the multiple dosing of IND (6 mg/kg/d for 7 d, p.o.) was significantly decreased as compared with that after a single dosing. In the multiple dose group coadministered magnesium silicate (0.6 g/kg), the AUC0 leads to infinity was 2 times that after the multiple dosing of IND alone. The repeated administration (8 times every 16 h) with IND (4 mg/kg) alone and IND plus the antacid respectively gave the results similar to those in the multiple dosing. In the multiple treated group with IND alone, the drug-metabolizing enzyme activities were significantly decreased (32-43%) as compared with the control, however, the coadministration of magnesium silicate partly protected the decrease. The intestinal absorption rate constant of IND determined by in situ method was decreased after the multiple dosing of IND alone, but the constant was recovered to the control value after coadministration of the antacid. Following the multiple dosing of IND alone, the centrilobular necrosis in liver and a partial omission of the villi of intestinal epithelium were observed, but the concurrent dosing of magnesium silicate did not produce histopathological changes.
D000818:Animals; D000863:Antacids / Q000494:pharmacology*; D003509:Cyclohexanecarboxylic Acids / Q000494:pharmacology*; D004025:Dicyclomine / Q000494:pharmacology*; D006207:Half-Life; D007213:Indomethacin / Q000008:administration & dosage / Q000378:metabolism*; D007408:Intestinal Absorption / Q000187:drug effects*; D007413:Intestinal Mucosa / Q000187:drug effects / Q000201:enzymology; D007700:Kinetics; D008099:Liver / Q000187:drug effects; D008297:Male; D008862:Microsomes, Liver / Q000201:enzymology; D051381:Rats; D011919:Rats, Inbred Strains
D000863:Antacids; D003509:Cyclohexanecarboxylic Acids; D004025:Dicyclomine; D007213:Indomethacin